A Unique Bond: human and animal health
At Boehringer Ingelheim we are dedicated to animal and human health. We celebrate the truly unique bonds between people and their pets.
Szukaj
More Health Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Collaboration Driving Innovation
In conversation with Dr. Megan Grether, Global Head of Business Development & Licensing, Boehringer Ingelheim Animal Health.
Covid19 relief program Ghana Cowtribe parasiticides
Boehringer Ingelheim and Cowtribe are kicking off a vital relief initiative in Ghana.
Labor & Human Rights
Suppliers shall support and respect the protection of internationally proclaimed human rights.
Our Approach
We are driven by the desire to improve human and animal health -– now and in the future. Therefore, we have developed our framework: Sustainable Development – For Generations.
Big hearts united to help animals in Ukraine
Veterinaries volunteer at the Polish-Ukrainian border to help welcome Refugees and their animals. Refugees don’t rest until their animals are safe.
Bigger role in ensuring food security
As the world population is projected to reach 9.8 billion in 2050, animal health becomes fundamental to ensure both animal well-being and global protein supply.
Equestrian sports technology
Learn about new trends in equine health and get insights into the human-horse relationship!
Antibody therapeutics business partnering PetMedix
Combining PetMedix’ expertise in veterinary biotherapeutic technology with Boehringer Ingelheim’s long experience and innovation in human antibody discovery and development provides a unique opportunity for the partners.
More Potential Overview
Working at the intersection of human and animal health, we have unique opportunities to positively impact vulnerable populations.
Retinal health
We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in Retinal Health.
Our Partnering Culture
We embrace the power of partnerships and alliances to find even more breakthrough therapies that change lives.
Guardians for health
sA global initiative to reduce mortality, cardiovascular and kidney complications in type 2 diabetes through adherence to clinical guideline.
“Rapid progress towards clinical candidates”
Boehringer Ingelheim forms a joint venture to create the next generation of antimicrobials.
Retinal Health Research
Read about our holistic approach to retinal health research.
Advancing regenerative medicine
Strategic partnerships play a key role in helping the company accelerate the next generation of breakthroughs.
Heart murmur in dogs: symptoms and how to treat it
Monitoring your dog’s heart can save its life
Stem cells a new frontier
Stem cells may be a game changer for the development of new veterinary treatments. Read this story to find out why.
Nerandomilast osiągnął pierwszorzędowy punkt końcowy w badaniu FIBRONEER™-IPF
Nerandomilast osiągnął pierwszorzędowy punkt końcowy w badaniu FIBRONEER™-IPF
BI Access to Healthcare Strategy_Availability
Boehringer Ingelheim aspires to be a leader in ensuring improved access by delivering More Health to humans, animals and communities around the world. Read more about our holistic approach, based on partnerships and local empowerment.
Firma Boehringer Ingelheim przekazała grant humanitarny w wysokości 50 000 euro dla Polskiego Stowarzyszenia Diabetyków
Firma Boehringer Ingelheim przekazała grant humanitarny w wysokości 50 000 euro dla Polskiego Stowarzyszenia Diabetyków
Partnering Vanderbilt WCNDD
Boehringer Ingelheim and the Warren Center for Neuroscience Drug Discovery are partnering to find new medicines for patients with neuropsychiatric disorders.
Let’s meet the challenge
Together with our partners around the world, we are working on new and innovative solutions for unmet medical need in animal health.
Boehringer Ingelheim Polska nowym partnerem Warsaw Health Innovation Hub
Boehringer Ingelheim Polska nowym partnerem Warsaw Health Innovation Hub